Table 1:
Characteristics and Demographics of COVID-19 Patients
| Total (N=39) | IMV-alone (N=21) | RVAD/ECMO (N=18) | p-value | |
|---|---|---|---|---|
| Age (years) | 53 (44 – 61) | 58 (42 – 67) | 51 (44 – 57) | .17 |
| Gender | .43 | |||
| Female | 20 (51.3%) | 12 (57.1%) | 8 (44.4%) | |
| Male | 19 (48.7%) | 9 (42.9%) | 10 (55.6%) | |
| PaO2/FiO2 ratio | 83 (68.4 – 96.7) (N=31) | 93.3 (71 – 106) (N=17) | 71.9 (62 – 85) (N=14) | .039 |
| SpO2/FiO2 ratio | 88.5 (82 – 99) (N=24) | 91.5 (83.5 – 101.4) (N=20) | 68.5 (50 – 86) (N=4) | .063 |
| Race | .49 | |||
| African American | 19 (48.7%) | 12 (57.1%) | 7 (38.9%) | |
| Non-Hispanic White | 12 (30.8%) | 6 (28.6%) | 6 (33.3%) | |
| Other Race/Ethnicity | 8 (20.5%) | 3 (14.3%) | 5 (27.8%) | |
| Comorbidity Count | .67 | |||
| < 4 | 33 (84.6%) | 17 (80.9%) | 16 (88.9%) | |
| 4 – 5 | 6 (15.4%) | 4 (19.1%) | 2 (11.1%) | |
| Comorbid Condition | ||||
| Chronic Lung Disease | 13 (33.3%) | 6 (28.6%) | 7 (38.9%) | .50 |
| Hypertension | 22 (56.4%) | 13 (61.9%) | 9 (50.0%) | .46 |
| Coronary Artery Disease | 3 (7.7%) | 0 (0%) | 3 (16.7%) | .089 |
| Chronic Kidney Disease | 3 (7.7%) | 2 (9.5%) | 1 (5.6%) | 1.00 |
| Preoperative Hemodialysis | 0 (0%) | 0 (0%) | 0 (0%) | |
| Diabetes Mellitus | 15 (38.5%) | 9 (42.9%) | 6 (33.3%) | .54 |
| Obesity | 25 (64.1%) | 14 (66.7%) | 11 (61.1%) | .72 |
| Therapies Given | ||||
| Hydroxychloroquine | 24 (75%) (N=32) | 16 (76.2%) (N=21) | 8 (72.7%) (N=11) | .83 |
| Azithromycin | 24 (75%) (N=32) | 18 (85.7%) (N=21) | 6 (54.6%) (N=11) | .053 |
| Doxycycline | 11 (34.4%) (N=32) | 6 (28.6%) (N=21) | 5 (45.5%) (N=11) | .44 |
| Tocilizumab | 16 (41.0%) (N=39) | 5 (23.8%) (N=21) | 11 (61.1%) (N=18) | .025 |
| Prednisone | 7 (21.9%) (N=32) | 4 (19.1%) (N=21) | 3 (27.3%) (N=11) | .67 |
| Hydrocortisone | 5 (15.6%) (N=32) | 4 (19.1%) (N=21) | 1 (9.1%) (N=11) | .64 |
| Dexamethasone | 7 (21.9%) (N=32) | 6 (28.6%) (N=21) | 1 (9.1%) (N=11) | .37 |
| Convalescent Plasma | 14 (35.9%) (N=39) | 2 (9.5%) (N=21) | 12 (66.7%) (N=18) | .001 |
| Remdesivir | 2 (6.3%) (N=32) | 2 (9.5%) (N=21) | 0 (0%) (N=11) | .53 |
| Proning | 37 (97.4%) (N=38) | 19 (95%) (N=20) | 18 (100%) (N=18) | 1.00 |
IMV, invasive mechanical ventilation; RVAD/ECMO, right ventricular assist device/extracorporeal membrane oxygenation